68462-585Level 3
Aprepitant (Aprepitant)
**Product type:** Human Prescription Drug
**Active ingredient:** APREPITANT
**Strength:** 125 mg/1
**Dosage form:** Capsule
**Route:** Oral
**Labeler:** Glenmark Pharmaceuticals Inc., USA
**Marketing category:** ANDA (ANDA207777)
**Pharmacologic class:** Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
GET
/api/v1/systems/ndc_fda/nodes/68462-585Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.